Our lab has two funded PhDs to start in 2026 via the NorthWestBio programme

Project details here
www.gla.ac.uk/postgraduate...
...and here
www.gla.ac.uk/postgraduate...

Application deadline is Nov 21st 2025; apply here:
www.gla.ac.uk/postgraduate...

How certain is certain enough? | LSHTM When faced with a new health threat, there are three crucial questions we must consider. What is going on? What can we do about it? And how can we communicate these things effectively? This talk will

I'm giving a free public talk asking 'How certain is certain enough?' at @lshtm.bsky.social on Monday 24th November at 5.30pm, as part of the Global Health Lecture Series. From epidemic response and clinical trials to online misinformation and AI, I'll look at how truth emerges – and why it falters.

This is exactly the case for me. It’s both the requirement for me to always carry something and the implication that anyone with any modicum of power could then demand it (I.e you can’t use this service unless you do). That would be a major change and very open to abuse.

🚨 New @who.int guidance for malaria in crisis settings 🌍 🦟

Dr Bhargavi Rao, co-author, highlights the significance of the manual for frontline workers and the need to integrate malaria control into broader emergency response.

Read more: bit.ly/469Q1kd

The essential host genome for Cryptosporidium survival exposes metabolic dependencies that can be leveraged for treatment An arrayed microscopy-based CRISPR screen revealed host genes affecting multiple infection phenotypes of the intracellular parasite Cryptosporidium. Hits in the host cholesterol biosynthesis pathway a...

Our paper has finally graduated from pre-print to peer-reviewed, pretty much unscathed, and is out now! www.cell.com/cell/fulltex...

An exciting opportunity to start an independent position as a research fellow in protozoan parasitology at Christ's College, Cambridge and the Department of Pathology:
www.jobs.cam.ac.uk/job/52020/

For those interested in Masters in lab and field based research in infectious disease we have 3 fantastic programmes to choose from MSc Immunology, medical parasitology and entomology and medical microbiology. They benefit from very flexible module choices and summer projects in UK and abroad!

Congratulations! Great to also see such a well thought out policy. Some things wouldn’t translate well for institutions in UK but lots of examples of really good practice to emulate.

Delighted to share the final version of Richard Zhou's study on how the CD163 scavenger receptor cleans up after toxic haemoglobin spills out from our blood cells. An amazing grabber mechanism!
rdcu.be/ewPA2

But they can just live on tips right?

Fighting malaria as a patient and scientist - Nature Microbiology Fitsum Tadesse was infected with malaria as a young child in Ethiopia and faced challenges to access efficacious treatment during a time of widespread drug resistance. Today, as a scientist in Africa,...

From surviving malaria as a child to leading cutting-edge research on drug resistance in Africa. Dr Fitsum Tadesse @lshtm.bsky.social is fighting the parasite from both sides. A powerful story of science, and resilience 🧬🌍

Read his journey @NatureMicrobiol 📄
👉 bit.ly/4nWsb22

I like the idea that philosophers need write like they are posting on twitter and therefore need to hedge against all possible ways of people deliberately misunderstanding them!

Congratulations Matt! Very well deserved

Insights from the 2025 Gordon Research Conference | LSHTM Insights from the 2025 Gordon Research Conference | LSHTM

🦠 “An honour to present” — @leen-vanheer.bsky.social shares insights from the 2025 Gordon Research Conference on Malaria.

From rising resistance in Ethiopia to promising progress in SE Asia, her talk spotlighted urgent AMR trends in Plasmodium falciparum.

Read more 👉 bit.ly/4ef5C4o

Our latest story describes the amazing evolutionary battle between malaria parasite and human. The parasite evolved RIFINs to bind inhibitory KIR receptors and suppress immune cell function while humans have activating KIR receptors to bind these RIFINs to kill parasites!

I am so jealous that Cornell has a glass blowing service!

Yes as I found providing fathers access to leave via a transferable entitlement, as UK’s SPL, exacerbates gendered parenting norms and does not provide parents means to imagine the feasibility of sharing leave / care in practice (for shorter read!: bristoluniversitypressdigital.com/view/journal...)

But it’s not day to day spending so it isn’t from the same pot. It also has less effect on credit rating as it is an asset purchase. I think the OBR or IFS actually had a piece on this in response to Corbyn’s manifesto. I just tried to look for it but must have been on my deleted twitter!

The purchase cost associated with nationalisation becomes almost irrelevant. As long as market rate is paid, money is spent but government now has an asset that is directly equivalent in value (assuming we continue to need water). The only important question is whether it will be run better.

Researchers at @lshtm.bsky.social, led by @josebengoechea.bsky.social, will conduct a £2.2M study funded by UK MRC to investigate how Klebsiella pneumoniae silently colonises the gut before causing deadly infections. 🔬🦠

Read more 👉 bit.ly/4mNSreh

🇧🇼 Botswana’s Health Minister Dr. Stephen Modise visited @lshtm.bsky.social to strengthen ties in global health and infectious disease control.

Discussions focused on malaria elimination and equitable access to health education.
#GlobalHealth #Malaria

Read more 👉 bit.ly/43PcZf1

Do you want cancelled foreign subcontracts added to the list? Unfortunately I would have a couple of those to add to the list…

Nawsad presented our structure-guided design of RH5top, our latest blood stage-malaria vaccine immunogen, in talk and poster at the Malaria Gordon conference. The culmination of many studies from the lab and collaborators and doing well in pre-clinical testing! More soon.

NIH funding supporting the HMMER and Infernal software projects has been terminated. NIH states that our work, as well as all other federally funded research at Harvard, is of no benefit to the US.

Want to be part of a diverse student community making a difference in #GlobalHealth?

Our #students & recent graduates tell us why they chose to study with us, from inspiring lecturers to 1st class research, a truly global network & warm welcome 🌎

Find out more👉 www.lshtm.ac.uk/study/intern...

@sturalph.bsky.social giving the laudatio for Dominique who receives the Lifetime Achievement Award for malariology at BioMalPar. #EMBLMalaria

It’s the most wonderful (conference) time of the year. 🎶 Happy to be a part of BioMalPar XXI @EMBL in Heidelberg (obligatory picture of the ATC below 😊). Come see me at poster number 44 tomorrow to see what we have been up to. #EMBLMalaria

Richard Wheeler keeping us all awake in the post-lunch session with a great talk about swimming in trypanosomatid parasites #EIDsymp25

Please consider applying for a post doc in our lab if you have bioinformatics and wet lab skills, and are interested in parasites!

elxw.fa.em3.oraclecloud.com/hcmUI/Candid...

What exactly is it that you do anyway, Michael? with Professor Michael Marks | Professor Michael Marks’ inaugural lecture will explore his portfolio of research in global health, starting from his time as a clinical fellow at LSHTM living and working in the Pacific to his

Two weeks today (29th May) I will be giving my inaugural lecture @lshtm.bsky.social Open to people who are in London & online for those who are not.

Hugely grateful to a wonderful array of collaborators & colleagues around the world whose work really underpins the research I will be talking about.